DrugRepV_0822 | Prednisone | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Allergic rhinitis | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (55.325 %) | Approved, Vet approved | 27476412 |
DrugRepV_0894 | Prednisolone | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Congenital adrenal hyperplasia | Thyroiditis | Psoriatic arthritis | Rheumatoid arthritis | Ankylosing spondylitis | Bursitis | Acute gouty arthritis | Epicondylitis | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (54.415 %) | Approved, Vet approved | 27476412 |
DrugRepV_0928 | Triamcinolone Acetonide | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Allergic rhinitis | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (49.745 %) | Approved, Vet approved | 27476412 |
DrugRepV_1347 | Hydrocortisone | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Dermatoses | Immune and allergic disorders | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (45.325 %) | Approved, Vet approved | 27476412 |
DrugRepV_1348 | Hydrocortisone Acetate | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Dermatoses | Immune and allergic disorders | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (47.6 %) | Approved | 27476412 |
DrugRepV_1400 | Betamethasone | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Edocrine disorders, rheumatic disorders, collagen diseases | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (43.4 %) | Approved | 27476412 |
DrugRepV_2312 | Betamethasone Valerate | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Dermatoses | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | No significant decrease (3.99594087 %) | Approved | 27742486 |
DrugRepV_2443 | Betamethasone | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Edocrine disorders, rheumatic disorders, collagen diseases | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | No significant decrease (1.2771865 %) | Approved | 27742486 |
DrugRepV_2460 | Triamcinolone | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Allergic rhinitis | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | No significant decrease (0.85708189 %) | Approved | 27742486 |
DrugRepV_2587 | Prednisolone Acetate | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Congenital adrenal hyperplasia | Thyroiditis | Psoriatic arthritis | Rheumatoid arthritis | Ankylosing spondylitis | Bursitis | Acute gouty arthritis | Epicondylitis | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-1.3985941 %) | Approved, Vet approved | 27742486 |
DrugRepV_2756 | Triamcinolone Acetonide | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Allergic rhinitis | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-4.0201161 %) | Approved, Vet approved | 27742486 |
DrugRepV_2854 | Prednisolone | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Congenital adrenal hyperplasia | Thyroiditis | Psoriatic arthritis | Rheumatoid arthritis | Ankylosing spondylitis | Bursitis | Acute gouty arthritis | Epicondylitis | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-6.875743 %) | Approved, Vet approved | 27742486 |
DrugRepV_2855 | Betamethasone Dipropionate | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Edocrine disorders, rheumatic disorders, collagen diseases | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-6.8812088 %) | Approved | 27742486 |
DrugRepV_2900 | Hydrocortisone | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Dermatoses | Immune and allergic disorders | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-9.1034782 %) | Approved, Vet approved | 27742486 |
DrugRepV_2912 | Prednisone | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Allergic rhinitis | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-9.8505525 %) | Approved, Vet approved | 27742486 |
DrugRepV_6010 | Prednisolone | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Congenital adrenal hyperplasia | Thyroiditis | Psoriatic arthritis | Rheumatoid arthritis | Ankylosing spondylitis | Bursitis | Acute gouty arthritis | Epicondylitis | Dengue virus | NA | | Plasma viremia | Decrease (3.2 Log) | Approved, Vet approved | 22865871 |
DrugRepV_6011 | Prednisolone | Alimentary Tract And Metabolism; Cardiovascular agents; Dermatologicals; Systemic Hormonal Preparati | Congenital adrenal hyperplasia | Thyroiditis | Psoriatic arthritis | Rheumatoid arthritis | Ankylosing spondylitis | Bursitis | Acute gouty arthritis | Epicondylitis | Dengue virus | NA | | Plasma viremia | Decrease (3.2 Log) | Approved, Vet approved | 22865871 |